ras gene mutations in salivary gland tumors

Archives of Pathology and Laboratory Medicine

Volumn 124, Issue 6, 2000, Pages 836-839

  Yoo, Jinyoung ^a   Robinson, Robert A ^b,c  

^a The Catholic University of Korea   (South Korea)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ARTICLE; CARCINOGENESIS; DNA SEQUENCE; GENE MUTATION; HUMAN; HUMAN TISSUE; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE RAS; POINT MUTATION; SALIVARY GLAND TUMOR;

ADENOCARCINOMA; ADOLESCENT; AGED; BASE SEQUENCE; CARCINOMA; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, MUCOEPIDERMOID; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; SALIVARY GLAND NEOPLASMS;

EID: 0034118544     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Bos JL. The ras gene family and human carcinogenesis. Mutat Res. 1988; 195:255-271.
2. Barbacid M. ras genes. Ann Rev Biochem. 1987;56:779-827.
3. Siegfried JM, Tod Gillespie A, Mera R, et al. Prognostic value of specific KRAS mutations in lung adenocarcinomas. Cancer Epidemiol Biomarkers Prev. 1977;6:841-847.
4. Keohavong P, Zhu D, Melacrinos AC, et al. Detection of low-fraction K-ras mutations in primary lung tumors using a sensitive method. Int J Cancer. 1997; 74:162-170.
5. Motojima K, Furui J, Kohara N, et al. Expression of Kirsten-ras-p21 in gastric cancer correlates with tumor progression and is prognostic. Diagn Mol Pathol. 1994;3:184-191.